Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-α in macrophages
Open Access
- 27 May 2009
- journal article
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 16 (1) , 50
Abstract
Atorvastatin has been shown to reduce resistin expression in macrophages after pro-inflammatory stimulation. However, the mechanism of reducing resistin expression by atorvastatin is not known. Therefore, we sought to investigate the molecular mechanisms of atorvastatin for reducing resistin expression after proinflammatory cytokine, tumor necrosis factor-α (TNF-α) stimulation in cultured macrophages. Cultured macrophages were obtained from human peripheral blood mononuclear cells. TNF-α stimulation increased resistin protein and mRNA expression and atorvastatin inhibited the induction of resistin by TNF-α. Addition of mevalonate induced resistin protein expression similar to TNF-α stimulation. However, atorvastatin did not have effect on resistin protein expression induced by mevalonate. SP600125 and JNK small interfering RNA (siRNA) completely attenuated the resistin protein expression induced by TNF-α and mevalonate. TNF-α induced phosphorylation of Rac, while atorvastatin and Rac-1 inhibitor inhibited the phosphorylation of Rac induced by TNF-α. The gel shift and promoter activity assay showed that TNF-α increased AP-1-binding activity and resistin promoter activity, while SP600125 and atorvastatin inhibited the AP-1-binding activity and resistin promoter activity induced by TNF-α. Recombinant resistin and TNF-α significantly reduced glucose uptake in cultured macrophages, while atorvastatin reversed the reduced glucose uptake by TNF-α. In conclusion, JNK and Rac pathway mediates the inhibitory effect of atorvastatin on resistin expression induced by TNF-α.Keywords
This publication has 22 references indexed in Scilit:
- The molecular regulation of resistin expression in cultured vascular smooth muscle cells under hypoxiaJournal Of Hypertension, 2008
- Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy menClinical Endocrinology, 2007
- Resistin induces lipolysis and re‐esterification of triacylglycerol stores, and increases cholesteryl ester deposition, in human macrophagesFEBS Letters, 2007
- Plasma resistin levels correlate with determinants of the metabolic syndromeEuropean Journal of Endocrinology, 2007
- Resistin worsens cardiac ischaemia-reperfusion injuryBiochemical and Biophysical Research Communications, 2006
- Resistin is secreted from macrophages in atheromas and promotes atherosclerosisCardiovascular Research, 2006
- Effect of Atorvastatin on in vitro Expression of Resistin in Adipocytes and Monocytes/Macrophages and Effect of Atorvastatin Treatment on Serum Resistin Levels in Patients with Type 2 DiabetesPharmacology, 2005
- The potential role of resistin in atherogenesisAtherosclerosis, 2005
- Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteriesJournal of Vascular Surgery, 2005
- Resistin Promotes Smooth Muscle Cell Proliferation Through Activation of Extracellular Signal–Regulated Kinase 1/2 and Phosphatidylinositol 3-Kinase PathwaysCirculation, 2004